Company

PhysioWave was founded by a group of Stanford researchers who realized that one of the most meaningful measures of cardiovascular health, Pulse Wave Velocity (PWV), was not in widespread use because it was difficult to obtain. They invented a way to measure PWV in under a minute while a patient is being weighed, with no change to clinical workflow.

Realizing the potential of this technology to identify individuals at high risk of cardiovascular disease, the company developed a clinical product, with a clinically valid home version to follow.

PhysioWave’s mission is to help save millions of people from premature death due to cardiovascular disease.


Team

Marsh

Marsh Cuttino, M.D.

Chief Executive Officer

Emergency and Aerospace Medicine
Physician Leader
ApolloMD, EmCare, TEAMHealth

Greg

Greg Kovacs, M.D., Ph.D.

Founder, Chairman of the Board

CMO at Triple Ring Technologies
EE Professor/MD Stanford (Emeritus)
Co-founder Cepheid

Judith

Judith Swain, M.D.

Chief Medical Officer

Former Chair of Stanford Department of Medicine
Cardiologist
National Academy of Medicine

Bruce

Bruce Darling, Ph.D.

Chief Engineer, Co-Founder

EE Professor, University of Washington,
Broad biomedical engineering experience

Laurent

Laurent Giovangrandi, Ph.D.

Chief Technology Officer, Co-Founder

Principal Scientist/Engineer at Triple Ring Technologies
Physiologic Research & Algorithms
Previously Stanford, Malibu IQ


External Board Members

Darrell

Darrell Zoromski

Board Member

25+ years in medical and consumer product
Previously CEO of Miramar Labs, VP & CMO at Align Technology,
GM at Zeiss, Director at General Mills

Emory

Emory Anderson

Board Member

32+ years in healthcare, consumer electronics, and data communication
President and CEO of Intuity Medical
Previously with Adeza Biomedical, Indesys, Atary


Medical Advisors

Stan

Stanley G. Rockson

M.D., FACP, FACC
  • Chief of Consultative Cardiology, Stanford
  • Director of the Stanford Center for Lymphatic and Venous Disorders
  • Editor-in-Chief of Lymphatic Research and Biology
  • Editorial board of Angiology

Glenn

Glenn M. Chertow

M.D., M.P.H.
  • Division Chief of Nephrology at Stanford
  • Research focused on improving care for persons with acute and chronic kidney disease (CKD)
  • Formerly served on the faculties of:
    • Brigham and Women’s Hospital
    • Harvard Medical School
    • University of California San Francisco